Welcome
Social Determinants of Opioid Use: Establishing a Research Agenda to Inform Community and System Level Interventions
Wednesday, 9/9/2020 – 9:30 am – 3:45 pm
Recordings
Below are the Workshop recordings.
- Recording - Opening, Keynote, & Session 1 - Framework: Understanding the Role of Social and Community Factors in the Context of Past and Present Inequities
- Recording - Session 2 - Mechanisms: Pathways of Influence of Social Determinants on Opioid-Related Outcomes
- Recording - Morning Summary/Afternoon Overview & Session 3 - Interventions: Strategies to Intervene on Social Factors at the Interpersonal, Community, and System Levels
- Recording - Session 4 - Adoption and Scale Up: Moving Social Interventions to Practice to Reduce Opioid Use and Other Drug Use Disorders & Meeting Summary/Next Steps
Presentations
Below are the Workshop presentation slides.
Opening, Keynote and Summary
- Presentation - Lawrence A. Tabak, DDS, PhD, Principal Deputy Director, National Institutes of Health
- Presentation - Monica Webb Hooper, PhD, Deputy Director, National Institute on Minority Health and Health Disparities, NIH
- Presentation - Sandro Galea, MD, DrPH, Dean, Boston University School of Public Health
Session 1 - Framework: Understanding the Role of Social and Community Factors in the Context of Past and Present Inequities
- Presentation - Andrea Hussong, PhD, Professor, Psychology and Neuroscience, University of North Carolina at Chapel Hill
- Presentation - Debra Furr-Holden, PhD., C.S. Mott Endowed Professor of Public Health; Associate Dean for Public Health Integration and Director of the Flint Center for Health Equity Solutions, Michigan State University
- Presentation - Donald Warne, MD, MPH, Associate Dean, Diversity, Equity and Inclusion, School of Medicine and Health Sciences, University of North Dakota; Director, Indians Into Medicine (INMED) Program and Director, Public Health Program, University of North Dakota
- Presentation - Hillary Kunins, MD, MPH, Executive Deputy Commissioner of Mental Hygiene, New York City Department of Health; Mental Hygiene and Clinical Professor, Albert Einstein College of Medicine
Session 2 - Mechanisms: Pathways of Influence of Social Determinants on Opioid-Related Outcomes
- Presentation - Joshua Sharfstein, MD, Vice Dean for Public Health Practice and Community Engagement, Johns Hopkins University
- Presentation - Philip Fisher, PhD, Philip H. Knight Chair & Professor of Psychology; Director, Center for Translational Neuroscience, University of Oregon
- Presentation - Shannon Monnat, PhD, Lerner Chair and Director of the Lerner Center for Public Health Promotion, Syracuse University
- Presentation - Velma McBride Murry, PhD, Lois Autrey Betts Chair, Education and Human Development, University Professor, Vanderbilt University Medical Center and Peabody College of Vanderbilt University
Session 3 - Interventions: Strategies to Intervene on Social Factors at the Interpersonal, Community, and System Levels
- Presentation - Allison Barlow, PhD, MPH, Director, Center for American Indian Health, Johns Hopkins University
- Presentation - Deborah Gorman-Smith, PhD, Dean and Emily Klein Gidwitz Professor, School of Social Service Administration, University of Chicago
- Presentation - Karen Hellman, MA, Assistant Director, Inmate Programs and Reentry, Arizona Department of Corrections, Rehabilitation & Reentry
- Presentation - Kelly J. Kelleher, MD, Distinguished Professor of Pediatrics and Public Health and ADS Chair for Innovation in Pediatric Practice in the Colleges of Medicine and Public Health, The Ohio State University
- Presentation - Phillip Graham, DrPH, Director, Center on Social Determinants, Risk Behaviors, and Prevention Science, RTI International
Session 4 - Adoption and Scale Up: Moving Social Interventions to Practice to Reduce Opioid Use and Other Drug Use Disorders
- Presentation - Alison E. Cuellar, PhD, Professor, Health Administration and Policy, George Mason University; Vice Chair, CDC Community Preventive Services Task Force
- Presentation - Cherie Rooks-Peck, PhD, Lead Health Scientist and Team Lead of the Applied Prevention Science Team, Division of Overdose Prevention, Centers for Disease Control and Prevention & Natasha Underwood, PhD, MPH, Health Scientist, Applied Prevention Science Team, Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention
- Presentation - Craig PoVey, MSW, Prevention Administrator, Utah Division of Substance Abuse and Mental Health
- Presentation - Gail Maddox Taylor, MEd, Director, Office of Behavioral Health Wellness, Commonwealth of Virginia
Workshop Synopsis
Social determinants of health are conditions in which people are born, live, learn, work, play, worship, and age that affect a wide range of health and quality-of-life outcomes and risks that include environmental factors, complex interrelated social structures, and economic systems that shape these outcomes. While a multitude of social determinants influence opioid and other substance use outcomes (see LINK), this workshop will largely focus on social and community determinants which include, but are not limited to, social isolation, bias and discrimination, interpersonal violence, social capital, and collective efficacy.
This workshop will bring together experts in opioid and other drug use, social epidemiology, developmental science, health disparities, health policy, and interventions for socially and economically marginalized communities. Participants will identify research gaps and priorities to advance our understanding of how social determinants impact opioid and other drug use, and explore opportunities for high-impact, scalable strategies to intervene on malleable factors to prevent and improve opioid and other drug use outcomes.
Agenda
September 9, 2020
- Welcome and opening remarks
- Keynote address: Relationship of social determinants to early drug use, opioid and psychostimulant use, polydrug use, and injection drug use
- Session 1: Framework: Understanding the role of social and community factors in the context of past and present inequities
- Session 2: Mechanisms: Pathways of influence of social determinants on opioid-related outcomes
- Session 3: Interventions: Strategies to intervene on social factors at the interpersonal, community, and system levels
- Session 4: Adoption and scale-up: Moving social interventions to practice to reduce opioid use and other drug use disorders
- Meeting summary and next steps
Click here to view, print, or download a detailed agenda and speaker biographies.
Planning Committee
NIH HEAL Initiative Social Determinants Workshop Planning Committee
- Jennifer Alvidrez, NIMHD
- Frank Bandiera, NIA
- Aria Crump, NIDA
- Gaya Dowling, NIDA
- Kathy Etz, NIDA
- Minnjuan Flournoy-Floyd, NIDA
- Michelle Freund, NIDA
- Meyer Glantz, NIDA
- Amy Goldstein, NIDA
- Jacqueline Lloyd, NIH Office of Disease Prevention
- Carrie Mulford, NIDA
- Moira O’Brien, NIDA
- Carmen Rosa, NIDA
- Michele Rankin, NIDA
- Belinda Sims, NIDA
- Erica Spotts, NIH Office of Behavioral and Social Sciences Research
- Jorge Vizcaino-Riveros, NIDA